Concourse Financial Group Securities’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4
Closed -$61 2364
2022
Q3
$0 Sell
4
-776
-99% -$14.1K ﹤0.01% 2312
2022
Q2
$12K Sell
780
-4,676
-86% -$69.2K ﹤0.01% 1621
2022
Q1
$111K Buy
5,456
+5,455
+545,500% +$111K 0.01% 830
2021
Q4
$0 Buy
+1
New +$29 ﹤0.01% 2491
2021
Q3
Sell
-1
Closed -$24 2496
2021
Q2
$0 Hold
1
﹤0.01% 2454
2021
Q1
$0 Buy
+1
New +$17 ﹤0.01% 2438
2020
Q4
Sell
-2
Closed -$18 2378
2020
Q3
$0 Buy
2
+1
+100% +$8 ﹤0.01% 2280
2020
Q2
$0 Buy
+1
New +$6 ﹤0.01% 2300
2020
Q1
Sell
-1
Closed -$6 2343
2019
Q4
$0 Hold
1
﹤0.01% 2152
2019
Q3
$0 Hold
1
﹤0.01% 2195
2019
Q2
$0 Buy
+1
New +$4 ﹤0.01% 2418

Other funds holding CDMO

Concourse Financial Group Securities's CDMO Position: Q4 2022 in Review

Concourse Financial Group Securities sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 4 shares — an estimated $61 sold.

Concourse Financial Group Securities first reported a position in CDMO in Q2 2019 and held it in 11 quarters. The position peaked at $111K in Q1 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

  • Concourse Financial Group Securities reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 4 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $61.
  • Concourse Financial Group Securities first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2019 and held it in 11 quarters.
  • Concourse Financial Group Securities's Avid Bioservices, Inc. Common Stock position peaked at $111K in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Concourse Financial Group Securities's 13F filing for Q4 2022, filed 30 Jan 2023.